» Articles » PMID: 35696096

Effect of 6,7-dimethoxy-2,2-dimethyl-2H-chromene (agerarin) on the Recovery of Filaggrin Expression Through Targeting of Janus Kinases in the Inflammatory Skin

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Filaggrin (FLG) is a structural component of the stratum corneum that is essential for maintaining the barrier function of the skin and for the formation of natural moisturizing factors. 6,7-Dimethoxy-2,2-dimethyl-2H-chromene (Agerarin) is a bioactive compound derived from Ageratum houstonianum, a plant that is used as a traditional medicine to treat skin diseases. This study aimed to evaluate the effect of agerarin on skin inflammation in a dinitrochlorobenzene (DNCB)-induced atopic dermatitis mouse model. We found that the topical administration of agerarin ameliorates atopic dermatitis-like skin lesions. We also showed that agerarin restores the reduced filaggrin (FLG) expression in DNCB-applied skin sections. Moreover, agerarin decreased phosphorylation of JAK1 and JAK2 kinases to enhance FLG expression, which was reduced by TNFα+IFNγ and IL4+IL13 treatment, in HaCaT keratinocytes. These results demonstrate the feasibility of agerarin as a possible therapeutic against conditions of skin inflammation, such as atopic dermatitis, by improving the upregulation of FLG expression.

Citing Articles

Saikosaponin A Recovers Impaired Filaggrin Levels in Inflamed Skin by Downregulating the Expression of FRA1 and c-Jun.

Ahn S, Yeo H, Jung E, Kim T, Han J, Han Lee Y Molecules. 2024; 29(17).

PMID: 39274912 PMC: 11396542. DOI: 10.3390/molecules29174064.


FRA1:c-JUN:HDAC1 complex down-regulates filaggrin expression upon TNFα and IFNγ stimulation in keratinocytes.

Ahn S, Yeo H, Jung E, Lim Y, Han Lee Y, Shin S Proc Natl Acad Sci U S A. 2022; 119(37):e2123451119.

PMID: 36067301 PMC: 9477237. DOI: 10.1073/pnas.2123451119.


The Natural Janus Kinase Inhibitor Agerarin Downregulates Interleukin-4-Induced Expression in HaCaT Keratinocytes.

Lee J, Jung E, Yeo H, Ahn S, Lim Y, Han Lee Y Molecules. 2022; 27(13).

PMID: 35807451 PMC: 9268509. DOI: 10.3390/molecules27134205.


Cosmeceutical Therapy: Engaging the Repercussions of UVR Photoaging on the Skin's Circadian Rhythm.

Mahendra C, Ser H, Pusparajah P, Htar T, Chuah L, Yap W Int J Mol Sci. 2022; 23(5).

PMID: 35270025 PMC: 8911461. DOI: 10.3390/ijms23052884.

References
1.
Cotter D, Schairer D, Eichenfield L . Emerging therapies for atopic dermatitis: JAK inhibitors. J Am Acad Dermatol. 2017; 78(3 Suppl 1):S53-S62. DOI: 10.1016/j.jaad.2017.12.019. View

2.
Howell M, Kim B, Gao P, Grant A, Boguniewicz M, DeBenedetto A . Cytokine modulation of atopic dermatitis filaggrin skin expression. J Allergy Clin Immunol. 2007; 120(1):150-5. PMC: 2669594. DOI: 10.1016/j.jaci.2007.04.031. View

3.
Egawa G, Kabashima K . Multifactorial skin barrier deficiency and atopic dermatitis: Essential topics to prevent the atopic march. J Allergy Clin Immunol. 2016; 138(2):350-358.e1. DOI: 10.1016/j.jaci.2016.06.002. View

4.
Bajusz D, Ferenczy G, Keseru G . Ensemble docking-based virtual screening yields novel spirocyclic JAK1 inhibitors. J Mol Graph Model. 2016; 70:275-283. DOI: 10.1016/j.jmgm.2016.10.014. View

5.
Brandt E, Sivaprasad U . Th2 Cytokines and Atopic Dermatitis. J Clin Cell Immunol. 2011; 2(3). PMC: 3189506. DOI: 10.4172/2155-9899.1000110. View